Should Everyone Have Their Genome Sequenced at Birth?
Genomics England recently announced a pilot program of whole genome sequencing to screen for genetic diseases in 200,000 healthy seeming newborns.
Read MorePosted by Chris Wolski | Nov 18, 2021 | Sequencing Systems |
Genomics England recently announced a pilot program of whole genome sequencing to screen for genetic diseases in 200,000 healthy seeming newborns.
Read MorePosted by Chris Wolski | Nov 15, 2021 | Emerging & Zoonotic Diseases, Sequencing Systems, Unknown Origin & Other Cancer Types |
Researchers have developed a mulitiplex network that reveals underlying mechanisms of rare diseases for more accurate identification of genetic defects.
Read MorePosted by Chris Wolski | Nov 12, 2021 | Molecular Diagnostic Analyzers, Respiratory Disease |
Asuragen Inc. has launched a testing kit for research use that is designed to detect pathogenic variants in the CFTR gene that cause cystic fibrosis.
Read MorePosted by Chris Wolski | Nov 11, 2021 | Company News |
A partnership between Genomenon and Inozyme Pharma will make variant data on ENPP1 deficiency available to genetic testing labs across the world.
Read MorePosted by Chris Wolski | Nov 10, 2021 | Molecular Diagnostic Analyzers |
Thermo Fisher Scientific has expanded its diagnostics portfolio to support full qPCR assay development and testing workflow.
Read More